المؤلفون: Boris A. Kallmann, Stefan Ries, Jennifer S. Kullmann, Laura M. Quint, Ulrich Engelmann, Andrew Chan

المصدر: Therapeutic Advances in Neurological Disorders, Vol 14 (2021)

مصطلحات موضوعية: Neurology. Diseases of the nervous system, RC346-429

وصف الملف: electronic resource

Relation: https://doaj.org/toc/1756-2864

URL الوصول: https://doaj.org/article/3991bc1b2870421b89bfe667ff331ad1

المؤلفون: Stefan Ries, Ulrich Engelmann, Jennifer S Kullmann, Boris Kallmann, Laura M Quint, Andrew T. Chan

المصدر: Kallmann, Boris A; Ries, Stefan; Kullmann, Jennifer S; Quint, Laura M; Engelmann, Ulrich; Chan, Andrew (2021). Teriflunomide in relapsing-remitting multiple sclerosis: outcomes by age and pre-treatment status. Therapeutic advances in neurological disorders, 14, p. 17562864211005588. Sage 10.1177/17562864211005588 <http://dx.doi.org/10.1177/17562864211005588>
Therapeutic Advances in Neurological Disorders, Vol 14 (2021)
Therapeutic Advances in Neurological Disorders

مصطلحات موضوعية: 0301 basic medicine, Pre treatment, medicine.medical_specialty, 610 Medicine & health, multiple sclerosis, 03 medical and health sciences, chemistry.chemical_compound, 0302 clinical medicine, Internal medicine, Teriflunomide, medicine, observational, RC346-429, Original Research, Pharmacology, immunosenescence, treatment, business.industry, Multiple sclerosis, satisfaction, Immunosenescence, medicine.disease, pre-treatment, switch, 030104 developmental biology, Neurology, chemistry, Relapsing remitting, age, Observational study, Neurology (clinical), Neurology. Diseases of the nervous system, Once daily, business, 030217 neurology & neurosurgery

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::75354bdb730ef84846d2d7012b1034a2
https://boris.unibe.ch/157488/1/Kallmann__2021__Teriflunomide_in_relapsing_remitting_MS.pdf